Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

被引：483

作者：

Hallberg, Bengt ^{[1
]}

Palmer, Ruth H. ^{[1
]}

机构：

[1] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden

来源：

NATURE REVIEWS CANCER | 2013年 / 13卷 / 10期

基金：

瑞典研究理事会;

关键词：

ANAPLASTIC LYMPHOMA KINASE; LARGE-CELL LYMPHOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; NPM-ALK; LUNG-CANCER; MOLECULAR CHARACTERIZATION; DOWN-REGULATION; TRUNCATED FORM; GROWTH-FACTOR; FUSION GENE;

D O I：

10.1038/nrc3580

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer (NSCLC). The common activation of ALK has led to the use of the ALK tyrosine kinase inhibitor (TKI) crizotinib in a range of patient populations and to the rapid development of second-generation drugs targeting ALK. In this Review, we discuss our current understanding of ALK function in human cancer and the implications for tumour treatment.

引用

页码：685 / 700

页数：16

共 50 条

[31] Receptor Tyrosine Kinase Coactivation Networks in Cancer
Xu, Alexander M.
Huang, Paul H.
CANCER RESEARCH, 2010, 70 (10) : 3857 - 3860
[32] The Met tyrosine kinase receptor in development and cancer
Gentile, Alessandra
Trusolino, Livio
Comoglio, Paolo M.
CANCER AND METASTASIS REVIEWS, 2008, 27 (01) : 85 - 94
[33] Receptor tyrosine kinase inhibitors in thyroid cancer
Castellone, Maria Domenica
Carlomagno, Francesca
Salvatore, Giuliana
Santoro, Massimo
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (06) : 1023 - 1038
[34] Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du
Christine M. Lovly
Molecular Cancer, 17
[35] DIFFERENTLY SPLICED CDNAS OF HUMAN-LEUKOCYTE TYROSINE KINASE RECEPTOR TYROSINE KINASE PREDICT RECEPTOR PROTEINS WITH AND WITHOUT A TYROSINE KINASE DOMAIN AND A SOLUBLE RECEPTOR PROTEIN
TOYOSHIMA, H
KOZUTSUMI, H
MARU, Y
HAGIWARA, K
FURUYA, A
MIOH, H
HANAI, N
TAKAKU, F
YAZAKI, Y
HIRAI, H
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) : 5404 - 5408
[36] The AXL tyrosine kinase receptor contributes to ALK-inhibitor resistance in neuroblastoma.
Bhatnagar, Namrata
Luther, William
Sharma, Bandana
Liu, Qingsong
Gray, Nathanael
George, Rani E.
CANCER RESEARCH, 2013, 73 (08)
[37] Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion
Englund, C
Lorén, CE
Grabbe, C
Varshney, GK
Deleuil, F
Hallberg, B
Palmer, RH
NATURE, 2003, 425 (6957) : 512 - 516
[38] Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion
Camilla Englund
Christina E. Lorén
Caroline Grabbe
Gaurav K. Varshney
Fabienne Deleuil
Bengt Hallberg
Ruth H. Palmer
Nature, 2003, 425 : 512 - 516
[39] The Drosophila Receptor Tyrosine Kinase Alk Constrains Long-Term Memory Formation
Gouzi, Jean Y.
Bouraimi, Mikela
Roussou, Ilianna G.
Moressis, Anastasios
Skoulakis, Efthimios M. C.
JOURNAL OF NEUROSCIENCE, 2018, 38 (35): : 7701 - 7712
[40] ACQUIRED RESISTANCE TO ALK TYROSINE KINASE INHIBITORS
Sasaki, T.
Ohsaki, Y.
Pasi, J.
ANNALS OF ONCOLOGY, 2012, 23 : 80 - 80

← 1 2 3 4 5 →